We are live on ! Find out more
CCA

Conestoga Capital Advisors Portfolio holdings

AUM $4.6B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+5.92%
1 Year Est. Return
+16.08%
3 Year Est. Return
+47.77%
5 Year Est. Return
+64.2%
10 Year Est. Return
+537.64%
AUM
$1.65B
AUM Growth
+$152M
Cap. Flow
+$78.5M
Cap. Flow %
4.74%
Top 10 Hldgs %
30.2%
Holding
122
New
5
Increased
60
Reduced
31
Closed
9

Top Buys

Rank Stock Value
1
DSGX icon
Descartes Systems
DSGX
+$16.6M
2
WDFC icon
WD-40
WDFC
+$14.4M
3
JBTM
JBT Marel
JBTM
+$9.67M
4
LMAT icon
LeMaitre Vascular
LMAT
+$9.1M
5
TECH icon
Bio-Techne
TECH
+$8.73M

Top Sells

Rank Stock Value
1
VASC
Vascular Solutions Inc
VASC
+$43.7M
2
ABAX
Abaxis Inc
ABAX
+$11.4M
3
IRMD icon
iRadimed
IRMD
+$5.6M
4
NVEC icon
NVE Corp
NVEC
+$3.6M
5
MLAB icon
Mesa Laboratories
MLAB
+$712K

Sector Composition

Rank Sector Weight
1 Healthcare 25.02%
2 Industrials 23.76%
3 Technology 21.88%
4 Consumer Discretionary 7.35%
5 Materials 5.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MA icon
101
Mastercard
MA
$501B
$264K 0.02%
2,350
-625
-21% -$68.5K
HXL icon
102
Hexcel
HXL
$7.93B
$263K 0.02%
4,818
– –
DD icon
103
DuPont de Nemours
DD
$19B
$261K 0.02%
1,619
– –
GE icon
104
GE Aerospace
GE
$392B
$237K 0.01%
1,660
– –
XRAY icon
105
Dentsply Sirona
XRAY
$2.86B
$237K 0.01%
3,795
– –
PNC icon
106
PNC Financial Services
PNC
$102B
$222K 0.01%
1,850
– –
AMGN icon
107
Amgen
AMGN
$209B
$218K 0.01%
+1,330
New +$221K
VZ icon
108
Verizon
VZ
$195B
$218K 0.01%
4,462
+400
+10% +$20.1K
GOOGL icon
109
Alphabet (Google) Class A
GOOGL
$4.64T
$216K 0.01%
5,100
-1,000
-16% -$42K
IART icon
110
Integra LifeSciences
IART
$1.39B
$211K 0.01%
5,000
-3,000
-38% -$128K
ADBE icon
111
Adobe
ADBE
$102B
$203K 0.01%
1,560
-470
-23% -$55.2K
GOOG icon
112
Alphabet (Google) Class C
GOOG
$4.61T
$203K 0.01%
4,900
-1,000
-17% -$41K
ACTA
113
DELISTED
Actua Corp
ACTA
$201K 0.01%
14,300
-2,300
-14% -$32.2K
DHR icon
114
Danaher
DHR
$138B
– –
-3,226
Closed -$223K
ECL icon
115
Ecolab
ECL
$79.2B
– –
-1,990
Closed -$233K
HD icon
116
Home Depot
HD
$349B
– –
-1,810
Closed -$243K
IRMD icon
117
iRadimed
IRMD
$1.21B
– –
-504,600
Closed -$5.6M
NKE icon
118
Nike
NKE
$62B
– –
-4,100
Closed -$208K
SLB icon
119
SLB Ltd
SLB
$75.2B
– –
-2,795
Closed -$235K
WFC icon
120
Wells Fargo
WFC
$268B
– –
-3,702
Closed -$204K
VASC
121
DELISTED
Vascular Solutions Inc
VASC
– –
-778,246
Closed -$43.7M
ABAX
122
DELISTED
Abaxis Inc
ABAX
– –
-215,732
Closed -$11.4M
1 2 3 4
5

Similar funds

SCM
Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return
AG
AlTi Global New York $4.6B AUM 22.54% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.61B AUM 19.2% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
DWM
Dakota Wealth Management Palm Beach Gardens, Florida $4.62B AUM 33.09% 1-Year Est. Return
SCM
Shelton Capital Management Denver, Colorado $4.57B AUM 32.26% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return

Conestoga Capital Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, Conestoga Capital Advisors held 122 positions worth $1.65B, up 10% from $1.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Conestoga Capital Advisors deployed $78.5M of net new capital in Q1 2017, opening 5 new positions and adding to 60 existing holdings. Its largest new stake was LeMaitre Vascular: 387,690 shares worth $9.55M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 27% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was NVE Corp, an estimated $3.6M trimmed.

  • Conestoga Capital Advisors's largest Q1 2017 buy was LeMaitre Vascular: 387,690 shares worth $9.55M.
  • Conestoga Capital Advisors added most to Descartes Systems in Q1 2017, an estimated $16.6M increase.
  • Conestoga Capital Advisors's biggest Q1 2017 reduction was NVE Corp, cutting an estimated $3.6M.
  • Conestoga Capital Advisors fully exited Vascular Solutions Inc in Q1 2017, selling an estimated $43.7M.
  • Conestoga Capital Advisors's ten largest holdings make up 30% of its $1.65B portfolio in Q1 2017.
  • Conestoga Capital Advisors opened 5 new positions and closed 9 in Q1 2017.
  • Conestoga Capital Advisors's portfolio value rose 10% quarter-over-quarter to $1.65B.

Based on Conestoga Capital Advisors's 13F filing for Q1 2017, filed 19 Apr 2017.